BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26598234)

  • 1. miR-223 Deficiency Protects against Fas-Induced Hepatocyte Apoptosis and Liver Injury through Targeting Insulin-Like Growth Factor 1 Receptor.
    Qadir XV; Chen W; Han C; Song K; Zhang J; Wu T
    Am J Pathol; 2015 Dec; 185(12):3141-51. PubMed ID: 26598234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-150 Deficiency Protects against FAS-Induced Acute Liver Injury in Mice through Regulation of AKT.
    Chen W; Han C; Zhang J; Song K; Wang Y; Wu T
    PLoS One; 2015; 10(7):e0132734. PubMed ID: 26196694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of Mir155 prevents Fas-induced liver injury through up-regulation of Mcl-1.
    Chen W; Han C; Zhang J; Song K; Wang Y; Wu T
    Am J Pathol; 2015 Apr; 185(4):1033-44. PubMed ID: 25794705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYLD deletion triggers nuclear factor-κB-signaling and increases cell death resistance in murine hepatocytes.
    Urbanik T; Koehler BC; Wolpert L; Elßner C; Scherr AL; Longerich T; Kautz N; Welte S; Hövelmeyer N; Jäger D; Waisman A; Schulze-Bergkamen H
    World J Gastroenterol; 2014 Dec; 20(45):17049-64. PubMed ID: 25493017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed-onset caspase-dependent massive hepatocyte apoptosis upon Fas activation in Bak/Bax-deficient mice.
    Hikita H; Takehara T; Kodama T; Shimizu S; Shigekawa M; Hosui A; Miyagi T; Tatsumi T; Ishida H; Li W; Kanto T; Hiramatsu N; Shimizu S; Tsujimoto Y; Hayashi N
    Hepatology; 2011 Jul; 54(1):240-51. PubMed ID: 21425311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 prevents fas-induced liver injury through up-regulation of epidermal growth factor receptor.
    Li G; Han C; Xu L; Lim K; Isse K; Wu T
    Hepatology; 2009 Sep; 50(3):834-43. PubMed ID: 19585617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytosolic phospholipase A(2)α protects against Fas- but not LPS-induced liver injury.
    Li G; Chen W; Han C; Wu T
    J Hepatol; 2011 Dec; 55(6):1281-90. PubMed ID: 21703211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colchicine protects mice from the lethal effect of an agonistic anti-Fas antibody.
    Feng G; Kaplowitz N
    J Clin Invest; 2000 Feb; 105(3):329-39. PubMed ID: 10675359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis.
    Hatano E; Bennett BL; Manning AM; Qian T; Lemasters JJ; Brenner DA
    Gastroenterology; 2001 Apr; 120(5):1251-62. PubMed ID: 11266388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ablation of c-FLIP in hepatocytes enhances death-receptor mediated apoptosis and toxic liver injury in vivo.
    Schattenberg JM; Zimmermann T; Wörns M; Sprinzl MF; Kreft A; Kohl T; Nagel M; Siebler J; Schulze Bergkamen H; He YW; Galle PR; Schuchmann M
    J Hepatol; 2011 Dec; 55(6):1272-80. PubMed ID: 21703207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the apelin receptor APJ in Fas-induced liver injury.
    Yasuzaki H; Yoshida S; Hashimoto T; Shibata W; Inamori M; Toya Y; Tamura K; Maeda S; Umemura S
    Liver Int; 2013 Jan; 33(1):118-26. PubMed ID: 23121371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms.
    Haga S; Terui K; Zhang HQ; Enosawa S; Ogawa W; Inoue H; Okuyama T; Takeda K; Akira S; Ogino T; Irani K; Ozaki M
    J Clin Invest; 2003 Oct; 112(7):989-98. PubMed ID: 14523036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation.
    Zheng TS; Hunot S; Kuida K; Momoi T; Srinivasan A; Nicholson DW; Lazebnik Y; Flavell RA
    Nat Med; 2000 Nov; 6(11):1241-7. PubMed ID: 11062535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced sensitivity to CD95-induced apoptosis in ob/ob mice.
    Siebler J; Schuchmann M; Strand S; Lehr HA; Neurath MF; Galle PR
    Dig Dis Sci; 2007 Sep; 52(9):2396-402. PubMed ID: 17415659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspase Inhibition Reduces Hepatic Tissue Factor-Driven Coagulation In Vitro and In Vivo.
    Kopec AK; Spada AP; Contreras PC; Mackman N; Luyendyk JP
    Toxicol Sci; 2018 Apr; 162(2):396-405. PubMed ID: 29228388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recql5 protects against lipopolysaccharide/D-galactosamine-induced liver injury in mice.
    Liao WQ; Qi YL; Wang L; Dong XM; Xu T; Ding CD; Liu R; Liang WC; Lu LT; Li H; Li WF; Luo GB; Lu XC
    World J Gastroenterol; 2015 Sep; 21(36):10375-84. PubMed ID: 26420964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas-induced apoptosis in mouse hepatocytes is dependent on C/EBPbeta.
    Mukherjee D; Kaestner KH; Kovalovich KK; Greenbaum LE
    Hepatology; 2001 May; 33(5):1166-72. PubMed ID: 11343245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas-induced apoptosis increases hepatocyte tissue factor procoagulant activity in vitro and in vivo.
    Lopez M; Kopec AK; Joshi N; Geddings JE; Cline H; Towery KL; Rockwell CE; Mackman N; Luyendyk JP
    Toxicol Sci; 2014 Oct; 141(2):453-64. PubMed ID: 25015658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The strength of the Fas ligand signal determines whether hepatocytes act as type 1 or type 2 cells in murine livers.
    Schüngel S; Buitrago-Molina LE; Nalapareddy Pd; Lebofsky M; Manns MP; Jaeschke H; Gross A; Vogel A
    Hepatology; 2009 Nov; 50(5):1558-66. PubMed ID: 19711425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte growth factor protects against Fas-mediated liver apoptosis in transgenic mice.
    Suzuki H; Toyoda M; Horiguchi N; Kakizaki S; Ohyama T; Takizawa D; Ichikawa T; Sato K; Takagi H; Mori M
    Liver Int; 2009 Nov; 29(10):1562-8. PubMed ID: 19725891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.